External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer

Brachytherapy

Volumn 1, Issue 1, 2002, Pages 36-41

  Potters, Louis ^a   Fearn, Paul ^a   Kattan, Michael W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Matched pair analysis; Nomogram; Prostate neoplasm; Radiotherapy

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DEMOGRAPHY; FOLLOW UP; HUMAN; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RISK FACTOR; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0038406126     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-4721(02)00008-9     Document Type: Article

References (26)

1. Potters L. Permanent prostate brachytherapy. Lessons learned, lessons to learn Oncology (Huntingt). 14:2000;981-991.
2. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 35:1996;875-879.
3. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 37:1997;559-563.
4. Stokes S.H., Real J.D., Adams P.W.et al. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 37:1997;337-341.
5. Ragde H., Elgamal A.A., Snow P.B.et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
6. Stock R.G., Stone N.N., DeWyngaert J.K.et al. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer. 77:1996;2386-2392.
7. Nag S., Beyer D., Friedland J.et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 44:1999;789-799.
8. Critz F.A., Williams W.H., Levinson A.K.et al. Simultaneous irradiation for prostate cancer. Intermediate results with modern techniques J Urol. 164:2000;738-741.
9. Potters L., Cha C., Ashley R.et al. The role of external beam irradiation in patients undergoing prostate brachytherapy. Urol Oncol. 5(3):2000;112-117.
10. Fleming I.D., Cooper J.S., Henson D.E.et al. AJCC cancer staging manual. 5th ed:; 1997;Lippincott-Raven, Philadelphia.
11. Beyer D., Nath R., Butler W.et al. American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for (103) palladium brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;273-275.
12. Nath R., Roberts K., Ng M.et al. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys. 25:1998;2293-2307.
13. Stone N.N., Stock R.G. Brachytherapy for prostate cancer. Real-time three-dimensional interactive seed implantation Tech Urol. 1:1995;72-80.
14. Potters L., Cao Y., Calugaru E.et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 50:2001;605-614.
15. Consensus statement: Guidelines for PSA following radiation therapy American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
16. Kattan M.W., Fearn P.A., Leibel S.et al. The definition of biochemical failure in patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 48:2000;1469-1474.
17. Cox D.R., Abadir R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
18. Partin A.W., Kattan M.W., Subong E.N.et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 277:1997;1445-1451.
19. Davis B.J., Pisansky T.M., Meyers R.P.et al. The radial distance of extraprostatic extension of prostate adenocarcinoma. Implications for prostate brachytherapy Cancer. 85:1999;2630-2637.
20. Zelefsky M.J., Yamada Y., Cohen G.et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation. Improved dose distributions with an intraoperative computer-optimized conformal planning technique Int J Radiat Oncol Biol Phys. 48:2000;601-608.
21. Blasko J.C., Grimm P.D., Sylsvester J.E.et al. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol. 57:2000;273-278.
22. Ragde H., Korb L.J., Elgamal A.A.et al. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer. 89:2000;135-141.
23. Gelblum D.Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;119-124.
24. Gelblum D., Potters L., Ashley R.et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 45:1999;59-67.
25. Zeitlin S.I., Sherman J., Raboy A.et al. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol. 160:1998;91-95.
26. Brandeis J.M., Litwin M.S., Burnison C.M.et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 163:2000;851-857.